Zobrazeno 1 - 10
of 246
pro vyhledávání: '"Hans‐Ulrich Schildhaus"'
Autor:
Marija Djukic, Johannes Gossner, Jörg Larsen, Fatima Barbara König, Hans‐Ulrich Schildhaus, Veit Rohde, Roland Nau
Publikováno v:
Clinical Case Reports, Vol 12, Iss 5, Pp n/a-n/a (2024)
Key Clinical Message Hypophyseal dysfunction may be overlooked by the currently generally accepted laboratory routine for the differential diagnosis in patients suffering from symptoms of depression or dementia. Abstract Hypothyroidism is an importan
Externí odkaz:
https://doaj.org/article/5317e7e568d3480899d7047d1f9fb674
Autor:
Sandra Schöniger, Sophie Degner, Claudia Schandelmaier, Heike Aupperle-Lellbach, Qian Zhang, Hans-Ulrich Schildhaus
Publikováno v:
Animals, Vol 14, Iss 14, p 2060 (2024)
For mammary carcinomas in pet rabbits, prognostic biomarkers are poorly defined, and treatment is limited to surgical excision. Additional treatment options are needed for rabbit patients for which surgery is not a suitable option. In human breast ca
Externí odkaz:
https://doaj.org/article/11b1c9aaa4d94efc8cc92cc4029a4d85
Autor:
Benedikt M. Schaarschmidt, Alexis Slama, Stéphane Collaud, Özlem Okumus, Hannah Steinberg, Sebastian Bauer, Hans-Ulrich Schildhaus, Jens Theysohn, Clemens Aigner
Publikováno v:
European Radiology Experimental, Vol 6, Iss 1, Pp 1-11 (2022)
Abstract Background Transpulmonary embolisation (TPE) using degradable starch microspheres (DSM) is a potential approach to treat pulmonary metastases. However, there is a paucity of detailed information on perfusion dynamics. The aim of this study w
Externí odkaz:
https://doaj.org/article/b443f183da9d43eabe3b2bf04fd99037
Autor:
Carolin Krekeler, Klaus Wethmar, Jan-Henrik Mikesch, Andrea Kerkhoff, Kerstin Menck, Georg Lenz, Hans-Ulrich Schildhaus, Michael Wessolly, Matthias W. Hoffmann, Andreas Pascher, Inga Asmus, Eva Wardelmann, Annalen Bleckmann
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 15, p 12056 (2023)
DNA mismatch repair deficient (dMMR) and microsatellite instable (MSI) metastatic colorectal cancer (mCRC) can be successfully treated with FDA- and EMA-approved immune checkpoint inhibitors (ICI) pembrolizumab and nivolumab (as single agents targeti
Externí odkaz:
https://doaj.org/article/d54ab952bd2342a491d0c232b97b1a54
Autor:
Theresa Stork, Rebecca Boemans, Jendrik Hardes, Arne Streitbürger, Uta Dirksen, Christoph Pöttgen, Hans-Ulrich Schildhaus, Sebastian Bauer, Stéphane Collaud, Clemens Aigner
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Pulmonary metastasectomy (PM) is an established treatment for selected patients with metastatic sarcomas. The aim of this study was to examine our institutional experience and evaluate factors predicting outcome. Methods We retros
Externí odkaz:
https://doaj.org/article/cbea41d6fb6447c5ba12f752307bf383
Autor:
Omar Elakad, Anna‐Maria Lois, Katja Schmitz, Sha Yao, Sara Hugo, Laura Lukat, Marc Hinterthaner, Bernhard C. Danner, Alexander vonHammerstein‐Equord, Kirsten Reuter‐Jessen, Hans‐Ulrich Schildhaus, Philipp Ströbel, Hanibal Bohnenberger
Publikováno v:
Cancer Medicine, Vol 9, Iss 10, Pp 3574-3583 (2020)
Abstract Background Targeting fibroblast growth factor receptor 1 (FGFR1) is a potential treatment for squamous cell lung cancer (SQCLC). So far, treatment decision in clinical studies is based on gene amplification. However, only a minority of patie
Externí odkaz:
https://doaj.org/article/b11316f0c4c94414ad45bc3cdf35f622
Autor:
Josef Rüschoff, Annette Lebeau, Peter Sinn, Hans-Ulrich Schildhaus, Thomas Decker, Johannes Ammann, Claudia Künzel, Winfried Koch, Michael Untch
Publikováno v:
Breast, Vol 49, Iss , Pp 246-253 (2020)
Background: The German NIU HER2 model was developed based on five variables found to have statistically significant influences on HER2-positivity, to allow exploration of deviations between model-predicted and actual HER2-positivity rates as a measur
Externí odkaz:
https://doaj.org/article/031761f292f54ba593fe8d88242c9b41
Autor:
Martin Metzenmacher, Balazs Hegedüs, Jan Forster, Alexander Schramm, Peter A. Horn, Christoph A. Klein, Nicola Bielefeld, Till Ploenes, Clemens Aigner, Dirk Theegarten, Hans-Ulrich Schildhaus, Jens T. Siveke, Martin Schuler, Smiths S. Lueong
Publikováno v:
Translational Oncology, Vol 15, Iss 1, Pp 101279- (2022)
Background: Radiology is the current standard for monitoring treatment responses in lung cancer. Limited sensitivity, exposure to ionizing radiations and related sequelae constitute some of its major limitation. Non-invasive and highly sensitive meth
Externí odkaz:
https://doaj.org/article/d3b1076963f443d6a11522f1b04db4d4
Autor:
Dirk Schadendorf, Lucie Heinzerling, Jessica C Hassel, Lisa Zimmer, Ralf Gutzmer, Lisa Villabona, Selma Ugurel, Thomas Eigentler, Peter Mohr, Thilo Gambichler, Patrick Terheyden, Sebastian Haferkamp, Claudia Pfoehler, Carmen Loquai, Jürgen Christian Becker, Ulrike Leiter, Hans-Ulrich Schildhaus, Ivelina Spassova, Linda Kubat, Annalena Mohr, Hannah Björn Andtback, Jochen S Utikal, Kai Horny, Daniel Habermann, Daniel Hoffmann
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/9d5ed971c944418f96838e599806293f
Autor:
Matthias Preusser, Leonhard Müllauer, Anna S Berghoff, Sebastian Bauer, Gerwin Heller, Thomas Brodowicz, Wolfgang Lamm, Katharina Feldmann, Angelika M Starzer, Rainer Hamacher, Erwin Tomasich, Teresa Hatziioannou, Stefan Traint, Iris M Noebauer-Huhmann, Julia Furtner, Gabriele Amann, Hans-Ulrich Schildhaus
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Some sarcomas respond to immune checkpoint inhibition, but predictive biomarkers are unknown. We analyzed tumor DNA methylation profiles in relation to immunological parameters and response to anti-programmed cell death 1 (anti-PD-1) immun
Externí odkaz:
https://doaj.org/article/a79916ad1b1542e9b504874a3913dd32